Severe acute interstitial lung disease after BNT162b2 mRNA COVID-19 vaccination in a patient post HLA-haploidentical hematopoietic stem cell transplantation.

Ueno, Toshiyuki; Ohta, Takanori; Sugio, Yasuhiro; Ohno, Yuju; Uehara, Yasufumi

Ueno, Toshiyuki; Ohta, Takanori; Sugio, Yasuhiro; Ohno, Yuju; Uehara, Yasufumi.

Ueno T; Department of Hematology, Kitakyushu Municipal Medical Center, Fukuoka, Japan. toshi.u.57@gmail.com.
Ohta T; Department of Hematology, Kitakyushu Municipal Medical Center, Fukuoka, Japan.
Sugio Y; Department of Hematology, Kitakyushu Municipal Medical Center, Fukuoka, Japan.
Ohno Y; Department of Hematology, Kitakyushu Municipal Medical Center, Fukuoka, Japan.
Uehara Y; Department of Hematology, Kitakyushu Municipal Medical Center, Fukuoka, Japan.

Bone Marrow Transplant ; 57(5): 840-842, 2022 05.

Article in English | MEDLINE | ID: covidwho-1839511

Subject(s)

COVID-19; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Lung Diseases, Interstitial; BNT162 Vaccine; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Graft vs Host Disease/etiology; Humans; Lung Diseases, Interstitial/etiology; Lung Diseases, Interstitial/therapy; RNA, Messenger; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lung Diseases, Interstitial / Hematopoietic Stem Cell Transplantation / COVID-19 / Graft vs Host Disease Topics: Vaccines Limits: Humans Language: English Journal: Bone Marrow Transplant Journal subject: Transplantation Year: 2022 Document Type: Article Affiliation country: S41409-022-01633-6

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google